Last reviewed · How we verify
Diabetic renal disease
Approved treatments
- Avapro · Sanofi
Avapro works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure. - Cozaar · Merck & Co.
Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure. - Capozide 25/15 · Aarxion Anda Hlding
- Cozaar · Merck & Co.
Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor. - Avapro · Sanofi
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diabetic renal disease patent landscape — cliff calendar, originator estates, attackable patents
- Diabetic renal disease treatment landscape brief
- Diabetic renal disease treatment updates RSS
Frequently asked questions about Diabetic renal disease
What drugs treat Diabetic renal disease?
Tracked treatments include Avapro, Cozaar, Capozide 25/15.
What is the treatment for Diabetic renal disease?
Standard treatment for Diabetic renal disease includes Avapro, Cozaar, Capozide 25/15. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diabetic renal disease patent cliff · Diabetic renal disease CI report
- Treatment: Avapro · Sanofi
- Treatment: Cozaar · Merck & Co.
- Treatment: Capozide 25/15 · Aarxion Anda Hlding
- Treatment: Cozaar · Merck & Co.
- Treatment: Avapro · Sanofi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing